Alcon Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Alcon (ALC) Tops Q1 EPS by 10c, Revenues Beat
May 12, 2020 4:34 PM EDTAlcon (NYSE: ALC) reported Q1 EPS of $0.45, $0.10 better than the analyst estimate of $0.35. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.71 billion.
Solid first quarter sales of $1.8 billion, an increase of 3%, or 4% constant currencySuccessful launch of PATADAY strengthens Alcon's leadership in the US OTC allergy marketDecline in global demand for surgical procedures will negatively impact second quarter resultsFocus on associate safety, business continuity and financial flexibility"Our first quarter reflects... More
